Nature 2005: "Caution raised over SARS vaccine"
"Jab against one strain might worsen infection with others." nature.com/articles/news0…
"A cautionary note has been sounded for those developing vaccines against severe acute respiratory syndrome (SARS). Some vaccines could prove useless against certain strains, or even worsen the infection, a preliminary study suggests."
"The results show that the virus changes over time, so that a strain that crops up in one outbreak might be quite different from that in a later outbreak. "This virus is not standing still and we need to take this into account," Nabel says."
"This wouldn´t be the first case where exposure to one strain of a virus can worsen infection with another. In the mosquito-borne disease dengue fever, e.g., people who have been infected with one strain are likely to suffer a worse infection if they pick up a second strain."
"Figuring this out might thwart potential problems in vaccines"
Este hilo resume los problemas de seguridad y problemas a los que se ha visto enfrentada por 18 años la vacuna de virus inactivado contra el Sars Cov1, Mers y ahora Sars Cov2,ampliamente distribuida por SINOPHARM en muchos países latinoamericanos. ¿Qué tanto se ha avanzado?
Desde la aparición del SARS en 2003 las vacunas inactivadas fueron la 1° opción d desarrollo, pero desde el comienzo demostraron tener problemas serios de seguridad.
Los cuales posiblemente estén ocurriendo hoy en día.
Durante el hilo, observe la progresión d los años.
CDC 2005 Desarrollo de la vacuna contra el SARS:
"La seguridad de la vacuna inactivada es una preocupación seria; algunas proteínas virales pueden inducir respuestas inmunes o inflamatorias dañinas, incluso causando enfermedades SIMILARES al SARS" 🤔
13 May 2013: SARS-Like Virus Vaccine Unlikely, Experts Say
"Health officials said vaccines were unlikely to play a role in controlling the outbreak"
"The thing that really takes time is the regulation aspect of it," said Ksiazek, professor in the dept. of pathology at the Univ. of Texas Medical Branch, describing the lengthy process of proving safety and efficacy in animal models before even thinking about testing in humans."
"There was no vaccine for SARS," Atmar said. "But the public health system was able to control the infection and basically eradicate it. That might also work for this new coronavirus."
SARS vaccines: where are we?
"Data regarding the correlates of protection, animal models and the available evidence regarding potential vaccine ENHANCEMENT of SARS disease are discussed"
Inactivated virus vaccines
"However, despite high neutralizing antibody titers, protection was incomplete for all vaccine preparations and administration routes tested." 🤔@juancarlossaid
AdVs vectored SARS-CoV vaccines
"Interestingly, although the intramuscular route was more effective in inducing neutralizing SARS serum antibodies, the INTRANASAL route of administration induced IgA and was MORE EFFECTIVE in blocking SARS-CoV replication in nose and lung tissue"